125 related articles for article (PubMed ID: 12009275)
1. Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine.
Shokrgozar MA; Shokri F
Vaccine; 2002 May; 20(17-18):2215-20. PubMed ID: 12009275
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination.
Heijtink RA; Bergen Pv; Melber K; Janowicz ZA; Osterhaus AD
Vaccine; 2002 May; 20(17-18):2191-6. PubMed ID: 12009272
[TBL] [Abstract][Full Text] [Related]
3. Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.
Heijtink RA; van Bergen P; Paulij WP; de Man RA; Osterhaus AD
Vaccine; 2000 Feb; 18(15):1531-8. PubMed ID: 10618551
[TBL] [Abstract][Full Text] [Related]
4. Frequency analysis of HBsAg-specific B lymphocytes in high-responder individuals to recombinant hepatitis B vaccine: comparison of LDA and ELISPOT assays.
Shokrgozar MA; Sam MR; Amirkhani A; Shokri F
Scand J Immunol; 2006 Nov; 64(5):536-43. PubMed ID: 17032247
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers, and vaccinees.
Wang L; Lin SJ; Tsai JH; Tsai CH; Tsai CC; Yang CC
Med Microbiol Immunol; 2005 Jan; 194(1-2):33-8. PubMed ID: 15278448
[TBL] [Abstract][Full Text] [Related]
6. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of human anti-HBs from volunteers with hepatitis B vaccine boost vaccination by modified B-cell immortalization technique].
Lou HB; Zhou YP; Zhou FY; Zhang MX; Wei JF; Zeng YL; Wang JJ; Wang YJ; Wu AH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):949-52. PubMed ID: 20501364
[TBL] [Abstract][Full Text] [Related]
8. Enumeration of hepatitis B surface antigen-specific B lymphocytes in responder and non-responder normal individuals vaccinated with recombinant hepatitis B surface antigen.
Shokrgozar MA; Shokri F
Immunology; 2001 Sep; 104(1):75-9. PubMed ID: 11576223
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
[TBL] [Abstract][Full Text] [Related]
10. Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination.
Doedée AM; Kannegieter N; Öztürk K; van Loveren H; Janssen R; Buisman AM
Vaccine; 2016 Apr; 34(19):2281-9. PubMed ID: 26721327
[TBL] [Abstract][Full Text] [Related]
11. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
Cooreman MP; Leroux-Roels G; Paulij WP
J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
13. The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection.
Gregorek H; Madaliński K; Woynarowski M; Mikołajewicz J; Syczewska M; Socha J
Vaccine; 2000 Jan; 18(13):1210-7. PubMed ID: 10649622
[TBL] [Abstract][Full Text] [Related]
14. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
[TBL] [Abstract][Full Text] [Related]
15. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
[TBL] [Abstract][Full Text] [Related]
16. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
Zhou Z; Chen WS; Zhang HH; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
[TBL] [Abstract][Full Text] [Related]
17. Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.
Kato M; Hamada-Tsutsumi S; Okuse C; Sakai A; Matsumoto N; Sato M; Sato T; Arito M; Omoteyama K; Suematsu N; Okamoto K; Kato T; Itoh F; Sumazaki R; Tanaka Y; Yotsuyanagi H; Kato T; Kurokawa MS
J Gastroenterol; 2017 Sep; 52(9):1051-1063. PubMed ID: 28197802
[TBL] [Abstract][Full Text] [Related]
18. Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg.
Heijtink RA; van Bergen P; van Roosmalen MH; Sünnen CM; Paulij WP; Schalm SW; Osterhaus AD
Vaccine; 2001 Jun; 19(27):3671-80. PubMed ID: 11395201
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of serum IgG subclass distributions and anti-HBs response in healthy adults after hepatitis B vaccination].
Dinç But A; Ersoy Y; Ozerol IH; Firat M
Mikrobiyol Bul; 2005 Oct; 39(4):483-90. PubMed ID: 16544550
[TBL] [Abstract][Full Text] [Related]
20. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
